Predictive value of epigenetic alterations in head and neck squamous cell carcinoma
Open Access
- 16 June 2014
- journal article
- review article
- Published by Taylor & Francis Ltd in Molecular & Cellular Oncology
- Vol. 1 (2), e954827
- https://doi.org/10.1080/23723548.2014.954827
Abstract
Head and neck cancer collectively describes malignant tumors originating from the mucosal surface of the upper aerodigestive tract. These tumors pose a great threat to public health because of their high incidence and mortality. Traditional risk factors are tobacco and alcohol abuse. More recently, infection by high-risk types of human papilloma virus (HPV) has been identified as an additional risk factor, especially for oropharyngeal squamous cell carcinoma (OPSCC). Moreover, HPV-positive OPSCC is considered a distinct tumor entity with an improved clinical outcome compared to HPV-negative OPSCC. Epigenetic alterations act as key events in the pathogenesis of cancer and are of special interest for basic and translational oncology because of their reversible nature. This review provides a comprehensive summary of alterations of the epigenome in head and neck squamous cell carcinoma (HNSCC) with a focus on the methylome (hypomethylation and hypermethylation) and its predictive value in the evaluation of pathologic states and clinical outcome, or monitoring response rates to certain therapies.Keywords
This publication has 103 references indexed in Scilit:
- The future of epigenetic therapy in solid tumours—lessons from the pastNature Reviews Clinical Oncology, 2013
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Epigenetic modifications as therapeutic targetsNature Biotechnology, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerThe New England Journal of Medicine, 2010
- Genomewide Gene Expression Profiles of HPV-Positive and HPV-Negative Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2009
- Hypermethylation of E‐cadherin is an independent predictor of improved survival in head and neck squamous cell carcinomaCancer, 2008
- Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomasBritish Journal of Cancer, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- The Epigenomics of CancerCell, 2007
- Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomasEuropean Journal of Cancer, 2007